Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge

Amy Starosciak; Felipe De Los Rios La Rosa; Felipe de los Rios La Rosa

Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge

Amy Starosciak
, Felipe De Los Rios La Rosa
, Felipe de los Rios La Rosa

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Apr 1 2019

Disciplines

Cardiology
Cardiovascular Diseases
Diseases
Medicine and Health Sciences
Nervous System Diseases
Neurology

Access to Document

Maximum IV tPA Dose for Obese Patients is Associated with GreaterFinal published version, 926 KBLicense: Unspecified

Cite this

@conference{3848a25fff6d4acea23bb5fde65ae404,

title = "Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge",

author = "Amy Starosciak and \{De Los Rios La Rosa\}, Felipe and \{de los Rios La Rosa\}, Felipe",

year = "2019",

month = apr,

day = "1",

language = "American English",

}

TY - CONF

T1 - Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge

AU - Starosciak, Amy

AU - De Los Rios La Rosa, Felipe

AU - de los Rios La Rosa, Felipe

PY - 2019/4/1

Y1 - 2019/4/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3132

M3 - Presentation

ER -

Maximum IV tPA Dose for Obese Patients is Associated with Greater Likelihood of Hemorrhagic Conversion and Worse Functional Outcome at Discharge

Disciplines

Access to Document

Other files and links

Cite this